Journal
MOLECULAR CELL
Volume 49, Issue 6, Pages 1083-1096Publisher
CELL PRESS
DOI: 10.1016/j.molcel.2013.01.010
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [81071680, 81171936, 81171937]
- National Natural Science Foundation of Shanghai [12ZR1437200]
- Youth Start-Up Funding of SMMU [2011QN02]
- Major Projects of National Science and Technology [2011ZXJ09103-07C]
- National Key Basic Research Program of China [2007CB512403, 2009CB522402]
Ask authors/readers for more resources
Recently, long noncoding RNAs (IncRNAs) were found to be dysregulated in a variety of tumors. However, it remains unknown how and through what molecular mechanisms the expression of IncRNAs is controlled. In this study, we found that the IncRNA Low Expression in Tumor (IncRNA-LET) was generally downregulated in hepatocellular carcinomas, colorectal cancers, and squamous-cell lung carcinomas. We demonstrated that hypoxia-induced histone deacetylase 3 repressed IncRNA-LET by reducing the histone acetylation-mediated modulation of the IncRNA-LET promoter region. Interestingly, the downregulation of IncRNA-LET was found to be a key step in the stabilization of nuclear factor 90 protein, which leads to hypoxia-induced cancer cell invasion. Moreover, the relationship among hypoxia, histone acetylation disorder, low IncRNA-LET expression level, and metastasis was found in clinical hepatocellular carcinoma samples. These results advance our understanding of the role of IncRNA-LET as a regulator of hypoxia signaling and offer new avenues for therapeutic intervention against cancer progression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available